NCT03537859

Brief Summary

Hospitalization is a stressful event that might impact in a patient's recovery. Children are more susceptible to suffer acute stress as a result of a hospital stay. Stress is often quantized using cortisol levels, a substance which increases following stressful stimuli. Since stress management is important in a patient's recovery, different therapies are used and have been evaluated and proven effective to diminish cortisol levels such as play interventions and clown therapy. Nevertheless, they rely on volunteers or trained staff to perform them. Nowadays, technology such as augmented reality allow us to provide therapy without the need of volunteers. This project aims to test if augmented reality technology is effective in lowering salivary cortisol levels in hospitalized children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 25, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

June 5, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2019

Completed
Last Updated

May 8, 2019

Status Verified

May 1, 2019

Enrollment Period

8 months

First QC Date

May 15, 2018

Last Update Submit

May 6, 2019

Conditions

Keywords

hospitalized childsalivary cortisolaugmented reality

Outcome Measures

Primary Outcomes (1)

  • Change in salivary cortisol levels

    Cortisol of salivary samples will be analyzed with a commercial Enzyme Immune Assay kit (DRG , Germany).

    Salivary samples will be obtained before and after the 1 hour intervention and kept under -20ºC until collection of samples of all participants.

Secondary Outcomes (1)

  • Visual analogue scale (VAS)

    VAS will be given immediately after salivary collection.

Study Arms (2)

Augmented Reality (AR)

EXPERIMENTAL

Books with augmented reality plus an electronic tablet.

Other: Augmented Reality

Non Augmented Reality (NoAR)

OTHER

Conventional children book. No electronic device will be given to children.

Other: Non Augmented Reality

Interventions

Augmented reality children books. The books will have special markers. The device's camera will read the marker and show 2d and 3D animations with the book's theme.

Augmented Reality (AR)

Augmented reality book without electronic device. Since no electronic device will be provided, the children will not be able to see any augmented reality features of the book, making it a conventional children's book.

Non Augmented Reality (NoAR)

Eligibility Criteria

Age7 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Boys and girls aged 7 - 11
  • In appropriate conditions to read a book
  • Hospitalization ≥ 3 days
  • Capable of reading in Spanish.
  • Written assent and informed consent signed by parents

You may not qualify if:

  • Patients with adrenal diseases such as Cushing's or Addison Disease
  • Patients with steroid prescription

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Cayetano Heredia

Lima, 15102, Peru

Location

Related Publications (8)

  • Bsiri-Moghaddam K, Basiri-Moghaddam M, Sadeghmoghaddam L, Ahmadi F. The concept of hospitalization of children from the view point of parents and children. Iran J Pediatr. 2011 Jun;21(2):201-8.

    PMID: 23056788BACKGROUND
  • Mindru DE, Stanescu RS, Mioara CM, Duceac LD, Rugina A, Temneanu OR, Ungureanu M, Florescu L. STRESS IN PEDIATRIC PATIENTS--THE EFFECT OF PROLONGED HOSPITALIZATION. Rev Med Chir Soc Med Nat Iasi. 2016 Apr-Jun;120(2):417-23.

    PMID: 27483728BACKGROUND
  • Potasz C, De Varela MJ, De Carvalho LC, Do Prado LF, Do Prado GF. Effect of play activities on hospitalized children's stress: a randomized clinical trial. Scand J Occup Ther. 2013 Jan;20(1):71-9. doi: 10.3109/11038128.2012.729087. Epub 2012 Oct 18.

    PMID: 23078405BACKGROUND
  • Saliba FG, Adiwardana NS, Uehara EU, Silvestre RN, Leite VV, Faleiros FT, Padovani FH, De Gobbi JI. Salivary Cortisol Levels: The Importance of Clown Doctors to Reduce Stress. Pediatr Rep. 2016 Mar 31;8(1):6188. doi: 10.4081/pr.2016.6188. eCollection 2016 Mar 31.

    PMID: 27114816BACKGROUND
  • Berryman DR. Augmented reality: a review. Med Ref Serv Q. 2012;31(2):212-8. doi: 10.1080/02763869.2012.670604.

    PMID: 22559183BACKGROUND
  • Chicchi Giglioli IA, Pallavicini F, Pedroli E, Serino S, Riva G. Augmented Reality: A Brand New Challenge for the Assessment and Treatment of Psychological Disorders. Comput Math Methods Med. 2015;2015:862942. doi: 10.1155/2015/862942. Epub 2015 Aug 3.

    PMID: 26339283BACKGROUND
  • McCarthy AM, Hanrahan K, Kleiber C, Zimmerman MB, Lutgendorf S, Tsalikian E. Normative salivary cortisol values and responsivity in children. Appl Nurs Res. 2009 Feb;22(1):54-62. doi: 10.1016/j.apnr.2007.04.009.

    PMID: 19171296BACKGROUND
  • Alarcon-Yaquetto DE, Tincopa JP, Guillen-Pinto D, Bailon N, Carcamo CP. Effect of augmented reality books in salivary cortisol levels in hospitalized pediatric patients: A randomized cross-over trial. Int J Med Inform. 2021 Apr;148:104404. doi: 10.1016/j.ijmedinf.2021.104404. Epub 2021 Feb 4.

Study Officials

  • Dulce E. Alarcón-Yaquetto, BSc

    Universidad Peruana Cayetano Heredia

    PRINCIPAL INVESTIGATOR
  • Cesar P Cárcamo, MD PhD

    Universidad Peruana Cayetano Heredia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: After enrollment, patients will be allocated in either the AR group or the NoAR group. The order of the intervention will be randomly selected before recruitment. A 48 hour wash-out will take place before the second intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2018

First Posted

May 25, 2018

Study Start

June 5, 2018

Primary Completion

January 18, 2019

Study Completion

January 18, 2019

Last Updated

May 8, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will share

The Study Protocol in spanish and english will be available. As well as the Statistical Analysis Plan and the informed consent and assent forms (in spanish)

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
May 15, 2018
Access Criteria
Open Access
More information

Locations